Nikolas Naleid

4PUBLICATIONS
38CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 10, 2026
Long-Term Outcomes and Surgical Conversion After Immunotherapy in Microsatellite Instability-H Biliary Tract Cancers.

|Jul 02, 2025
Feasibility of Personalized and Tumor-Informed Circulating Tumor DNA Assay for Early Recurrence Detection in Patients With Hepatocellular Carcinoma.

Maen Abdelrahim, Alejandro Mejia, Abdullah Esmail

|Apr 16, 2025
Safety and Efficacy of Anti-Human Epidermal Growth Factor 2 Agents in the Treatment of Biliary Tract Cancers: A Systematic Review.

Nikolas Naleid, Omkar Pawar, Sakti Chakrabarti

|Mar 04, 2025
Real-World Tolerability of Capecitabine and Oxaliplatin in Patients in the United States With Localized Colorectal Cancer Undergoing Curative-Intent Treatment.

Veronica Mears, Nikolas Naleid, Omkar Pawar

Pageof 1

Frequent Collaborators

4 joint publications

Amit Mahipal

2 joint publications

Omkar Pawar

2 joint publications

Sakti Chakrabarti

1 joint publications

Veronica Mears